Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural constituent of postsynaptic actin cytoskeleton	POTEF POTEE POTEI	2.20e-05	11	104	3	GO:0098973
GeneOntologyMolecularFunction	ATP-dependent activity	ABCC1 MYH7 MYO5A RHOBTB3 MCM2 CHD8 IQCA1L KIF5B TNNT2 ATP2B1 ATP2B4	3.56e-04	614	104	11	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCC1 MYH7 RHOBTB3 MCM2 CHD8 IQCA1L KIF5B ATP2B1 ATP2B4	4.97e-04	441	104	9	GO:0016887
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	KRT9 POTEF POTEE POTEI TNNT2	5.95e-04	130	104	5	GO:0005200
GeneOntologyMolecularFunction	structural constituent of postsynapse	POTEF POTEE POTEI	6.10e-04	32	104	3	GO:0099186
GeneOntologyCellularComponent	centriolar satellite	CEP162 CNTRL TEX9 HOOK3 KIF5B PLK1	4.12e-05	128	103	6	GO:0034451
GeneOntologyCellularComponent	axoneme	CLXN EFCAB6 CENPF CEP162 CNTRL CFAP43 HYDIN	7.48e-05	207	103	7	GO:0005930
GeneOntologyCellularComponent	ciliary plasm	CLXN EFCAB6 CENPF CEP162 CNTRL CFAP43 HYDIN	7.71e-05	208	103	7	GO:0097014
GeneOntologyCellularComponent	histone acetyltransferase complex	POTEF POTEE BRPF1 POTEI TAF6	1.02e-04	94	103	5	GO:0000123
GeneOntologyCellularComponent	protein acetyltransferase complex	POTEF POTEE BRPF1 POTEI TAF6	1.65e-04	104	103	5	GO:0031248
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	CLXN EFCAB6 CENPF CEP162 CNTRL CFAP43 KIF5B HYDIN	1.75e-04	317	103	8	GO:0032838
GeneOntologyCellularComponent	acetyltransferase complex	POTEF POTEE BRPF1 POTEI TAF6	2.05e-04	109	103	5	GO:1902493
GeneOntologyCellularComponent	supramolecular fiber	CUL3 MYH7 KRT9 EFCAB6 MYO5A CEP162 POTEF FHOD3 POTEE HOOK3 KIF5B POTEI TNNI2 PLK1 TNNT2 ATP2B4	2.05e-04	1179	103	16	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	CUL3 MYH7 KRT9 EFCAB6 MYO5A CEP162 POTEF FHOD3 POTEE HOOK3 KIF5B POTEI TNNI2 PLK1 TNNT2 ATP2B4	2.22e-04	1187	103	16	GO:0099081
GeneOntologyCellularComponent	striated muscle thin filament	FHOD3 TNNI2 TNNT2	3.12e-04	27	103	3	GO:0005865
GeneOntologyCellularComponent	cytoplasmic region	CLXN EFCAB6 CENPF CEP162 CNTRL CFAP43 KIF5B HYDIN	4.11e-04	360	103	8	GO:0099568
GeneOntologyCellularComponent	NuA4 histone acetyltransferase complex	POTEF POTEE POTEI	5.19e-04	32	103	3	GO:0035267
GeneOntologyCellularComponent	myofilament	FHOD3 TNNI2 TNNT2	5.19e-04	32	103	3	GO:0036379
GeneOntologyCellularComponent	H4/H2A histone acetyltransferase complex	POTEF POTEE POTEI	5.19e-04	32	103	3	GO:0043189
GeneOntologyCellularComponent	troponin complex	TNNI2 TNNT2	8.46e-04	9	103	2	GO:0005861
GeneOntologyCellularComponent	H4 histone acetyltransferase complex	POTEF POTEE POTEI	1.42e-03	45	103	3	GO:1902562
GeneOntologyCellularComponent	cilium	CUL3 CLXN EFCAB6 TBC1D30 MYO5A CENPF CEP162 CNTRL CFAP43 KIF5B ATP2B4 HYDIN	1.55e-03	898	103	12	GO:0005929
GeneOntologyCellularComponent	chromatin	ZBTB33 CENPF POTEF MCM2 CHD8 NSD3 POTEE BRD2 FANCI BRPF1 TET1 RBPJ BRD9 POTEI TAF6 PLK1	2.35e-03	1480	103	16	GO:0000785
Domain	Ank_2	POTEB3 POTEF POTEG POTEC POTEE POTEM POTEI ZDHHC13 POTEH GABPB1	2.33e-07	215	100	10	PF12796
Domain	-	POTEB3 POTEF POTEG POTEC POTEE POTEM POTEI ZDHHC13 POTEH GABPB1	8.64e-07	248	100	10	1.25.40.20
Domain	ANK	POTEB3 POTEF POTEG POTEC POTEE POTEM POTEI ZDHHC13 POTEH GABPB1	9.63e-07	251	100	10	SM00248
Domain	ANK_REPEAT	POTEB3 POTEF POTEG POTEC POTEE POTEM POTEI ZDHHC13 POTEH GABPB1	1.04e-06	253	100	10	PS50088
Domain	Ankyrin_rpt-contain_dom	POTEB3 POTEF POTEG POTEC POTEE POTEM POTEI ZDHHC13 POTEH GABPB1	1.07e-06	254	100	10	IPR020683
Domain	ANK_REP_REGION	POTEB3 POTEF POTEG POTEC POTEE POTEM POTEI ZDHHC13 POTEH GABPB1	1.07e-06	254	100	10	PS50297
Domain	Ankyrin_rpt	POTEB3 POTEF POTEG POTEC POTEE POTEM POTEI ZDHHC13 POTEH GABPB1	1.42e-06	262	100	10	IPR002110
Domain	Ank	POTEF POTEG POTEC POTEE POTEM POTEI ZDHHC13 POTEH GABPB1	3.73e-06	228	100	9	PF00023
Domain	ATP2B1/4	ATP2B1 ATP2B4	2.84e-05	2	100	2	IPR030319
Domain	Actin_CS	POTEF POTEE POTEI	7.93e-05	16	100	3	IPR004001
Domain	ACTINS_2	POTEF POTEE POTEI	9.59e-05	17	100	3	PS00432
Domain	SET	PRDM5 NSD3 SMYD4 PRDM15	1.06e-04	46	100	4	SM00317
Domain	Actin/actin-like_CS	POTEF POTEE POTEI	1.15e-04	18	100	3	IPR020902
Domain	ACTINS_ACT_LIKE	POTEF POTEE POTEI	1.36e-04	19	100	3	PS01132
Domain	SET_dom	PRDM5 NSD3 SMYD4 PRDM15	1.47e-04	50	100	4	IPR001214
Domain	SET	PRDM5 NSD3 SMYD4 PRDM15	1.47e-04	50	100	4	PS50280
Domain	ATP_Ca_trans_C	ATP2B1 ATP2B4	1.69e-04	4	100	2	IPR022141
Domain	ATP_Ca_trans_C	ATP2B1 ATP2B4	1.69e-04	4	100	2	PF12424
Domain	P-type_ATPase_IIB	ATP2B1 ATP2B4	1.69e-04	4	100	2	IPR006408
Domain	Troponin	TNNI2 TNNT2	4.20e-04	6	100	2	PF00992
Domain	Troponin	TNNI2 TNNT2	4.20e-04	6	100	2	IPR001978
Domain	Actin	POTEF POTEE POTEI	6.00e-04	31	100	3	IPR004000
Domain	Actin	POTEF POTEE POTEI	6.00e-04	31	100	3	PF00022
Domain	ACTIN	POTEF POTEE POTEI	6.00e-04	31	100	3	SM00268
Domain	BROMODOMAIN_1	BRD2 BRPF1 BRD9	1.01e-03	37	100	3	PS00633
Domain	Bromodomain	BRD2 BRPF1 BRD9	1.10e-03	38	100	3	PF00439
Domain	SET	PRDM5 NSD3 SMYD4	1.37e-03	41	100	3	PF00856
Domain	BROMODOMAIN_2	BRD2 BRPF1 BRD9	1.37e-03	41	100	3	PS50014
Domain	BROMO	BRD2 BRPF1 BRD9	1.47e-03	42	100	3	SM00297
Domain	Bromodomain	BRD2 BRPF1 BRD9	1.47e-03	42	100	3	IPR001487
Domain	-	BRD2 BRPF1 BRD9	1.47e-03	42	100	3	1.20.920.10
Domain	ARM-type_fold	FHOD3 ARMCX2 SDAD1 ITPR2 MRO VPS35 TAF6	2.31e-03	339	100	7	IPR016024
Domain	-	PDZRN3 PDZRN4	2.48e-03	14	100	2	3.90.890.10
Domain	SIAH-type	PDZRN3 PDZRN4	3.24e-03	16	100	2	IPR013323
Domain	-	ATP2B1 ATP2B4	3.24e-03	16	100	2	1.20.1110.10
Domain	ATPase_P-typ_TM_dom	ATP2B1 ATP2B4	3.24e-03	16	100	2	IPR023298
Domain	ATPase_P-typ_cation-transptr_C	ATP2B1 ATP2B4	3.66e-03	17	100	2	IPR006068
Domain	Cation_ATPase_C	ATP2B1 ATP2B4	3.66e-03	17	100	2	PF00689
Domain	Cation_ATPase_N	ATP2B1 ATP2B4	4.11e-03	18	100	2	PF00690
Domain	Cation_ATPase_N	ATP2B1 ATP2B4	4.11e-03	18	100	2	SM00831
Domain	ATPase_P-typ_cation-transptr_N	ATP2B1 ATP2B4	4.57e-03	19	100	2	IPR004014
Domain	PWWP	NSD3 BRPF1	5.06e-03	20	100	2	SM00293
Pubmed	Identification of a novel actin isoform in hepatocellular carcinoma.	POTEF POTEG POTEE POTEM POTEI	6.68e-10	15	105	5	16824795
Pubmed	Two novel transcripts encoding two Ankyrin repeat containing proteins have preponderant expression during the mouse spermatogenesis.	POTEG POTEC POTEM POTEH	1.17e-09	6	105	4	17171436
Pubmed	Five POTE paralogs and their splice variants are expressed in human prostate and encode proteins of different lengths.	POTEB3 POTEG POTEE POTEH	2.73e-09	7	105	4	15276201
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ABCC1 MYO5A CEP162 SDAD1 NSD3 ITPR2 POSTN RFTN1 STXBP3 BRD2 FANCI LRRC1 CDC5L PLK1 SNRPD1 ATP2B1 ATP2B4	1.69e-08	1049	105	17	27880917
Pubmed	The Vertebrate Genome Annotation browser 10 years on.	POTEB3 POTEF POTEG POTEC POTEE POTEM POTEI POTEH	3.71e-08	163	105	8	24316575
Pubmed	Identification and characterization of TSAP, a novel gene specifically expressed in testis during spermatogenesis.	POTEC POTEM POTEH	1.07e-07	4	105	3	17342726
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH7 MYO5A CENPF POTEF CNTRL LAMP5 HNRNPF TASOR2 POTEE RFTN1 UTP18 BRD2 FAM50A VPS35 KIF5B POTEI CCDC191 ATP2B1	3.08e-07	1442	105	18	35575683
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	KRT9 FHOD3 CFAP43 SDAD1 TASOR2 POTEE IQCA1L CADPS LRRC1 POP1 PLK1	3.32e-07	496	105	11	31343991
Pubmed	Epigenetic repression of cardiac progenitor gene expression by Ezh2 is required for postnatal cardiac homeostasis.	MYH7 POSTN TNNI2 TNNT2	3.66e-07	20	105	4	22267199
Pubmed	POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer.	POTEB3 POTEC POTEH	1.48e-06	8	105	3	12475935
Pubmed	Duplication and extensive remodeling shaped POTE family genes encoding proteins containing ankyrin repeat and coiled coil domains.	POTEE POTEM POTEI	2.22e-06	9	105	3	16364570
Pubmed	Defining the membrane proteome of NK cells.	CUL3 ABCC1 KRT9 MYO5A CNTRL HNRNPF ITPR2 ANO6 FANCI KIF5B CDC5L APOL2 ZDHHC13 ATP2B1 ATP2B4	2.35e-06	1168	105	15	19946888
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	ZBTB33 CHD8 HNRNPF TASOR2 BRD2 RBPJ BRD9 CDC5L PLK1	4.55e-06	411	105	9	35182466
Pubmed	Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach.	DMXL2 KRT9 POTEF POTEE POP1 POTEI	6.34e-06	149	105	6	22664934
Pubmed	Histone deacetylase 3 modulates Tbx5 activity to regulate early cardiogenesis.	MYH7 TNNI2 TNNT2	7.48e-06	13	105	3	24565863
Pubmed	Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene.	MYH7 TNNT2	9.03e-06	2	105	2	15769782
Pubmed	Functional and structural demonstration of the presence of Ca-ATPase (PMCA) in both microvillous and basal plasma membranes from syncytiotrophoblast of human term placenta.	ATP2B1 ATP2B4	9.03e-06	2	105	2	18657858
Pubmed	A Variant Detection Pipeline for Inherited Cardiomyopathy-Associated Genes Using Next-Generation Sequencing.	MYH7 TNNT2	9.03e-06	2	105	2	25937619
Pubmed	Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy.	MYH7 TNNT2	9.03e-06	2	105	2	18029407
Pubmed	The influence of membrane lipid structure on plasma membrane Ca2+ -ATPase activity.	ATP2B1 ATP2B4	9.03e-06	2	105	2	16412504
Pubmed	A primate-specific POTE-actin fusion protein plays a role in apoptosis.	POTEF POTEE	9.03e-06	2	105	2	19669888
Pubmed	Distinct roles of PMCA isoforms in Ca2+ homeostasis of bladder smooth muscle: evidence from PMCA gene-ablated mice.	ATP2B1 ATP2B4	9.03e-06	2	105	2	16956963
Pubmed	Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.	MYH7 TNNT2	9.03e-06	2	105	2	11106718
Pubmed	Localization of two genes encoding plasma membrane Ca2(+)-transporting ATPases to human chromosomes 1q25-32 and 12q21-23.	ATP2B1 ATP2B4	9.03e-06	2	105	2	1674727
Pubmed	Long-term follow-up of R403WMYH7 and R92WTNNT2 HCM families: mutations determine left ventricular dimensions but not wall thickness during disease progression.	MYH7 TNNT2	9.03e-06	2	105	2	17612745
Pubmed	Targeted ablation of plasma membrane Ca2+-ATPase (PMCA) 1 and 4 indicates a major housekeeping function for PMCA1 and a critical role in hyperactivated sperm motility and male fertility for PMCA4.	ATP2B1 ATP2B4	9.03e-06	2	105	2	15178683
Pubmed	Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.	MYH7 TNNT2	9.03e-06	2	105	2	27082122
Pubmed	Role of plasma membrane Ca2+-ATPase in contraction-relaxation processes of the bladder: evidence from PMCA gene-ablated mice.	ATP2B1 ATP2B4	9.03e-06	2	105	2	16291816
Pubmed	Regulation of plasma membrane Ca2+-ATPase by small GTPases and phosphoinositides in human platelets.	ATP2B1 ATP2B4	9.03e-06	2	105	2	10748016
Pubmed	Selective upregulation of the expression of plasma membrane calcium ATPase isoforms upon differentiation and 1,25(OH)2D3-vitamin treatment of colon cancer cells.	ATP2B1 ATP2B4	9.03e-06	2	105	2	26116539
Pubmed	Abnormal blood pressure response to exercise occurs more frequently in hypertrophic cardiomyopathy patients with the R92W troponin T mutation than in those with myosin mutations.	MYH7 TNNT2	9.03e-06	2	105	2	19880069
Pubmed	Plasma membrane calcium ATPase regulates bone mass by fine-tuning osteoclast differentiation and survival.	ATP2B1 ATP2B4	9.03e-06	2	105	2	23266958
Pubmed	Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective.	MYH7 TNNT2	9.03e-06	2	105	2	12084606
Pubmed	Digenic inheritance of mutations in the cardiac troponin (TNNT2) and cardiac beta myosin heavy chain (MYH7) as the cause of severe dilated cardiomyopathy.	MYH7 TNNT2	9.03e-06	2	105	2	28642161
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	MCM2 CHD8 ARMCX2 TASOR2 BRD2 FANCI RBPJ CDC5L HYDIN	1.31e-05	469	105	9	27634302
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	CHD8 NSD3 BRD2 FAM50A FANCI BRPF1 RBPJ BRD9 SGO2 PRDM15	1.61e-05	608	105	10	36089195
Pubmed	Slow and fast fiber isoform gene expression is systematically altered in skeletal muscle of the Sox6 mutant, p100H.	MYH7 TNNI2 TNNT2	1.76e-05	17	105	3	16124007
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	RHOBTB3 NAB1 FAM76B STARD7 CHD8 ARMCX2 TASOR2 SMYD4 STXBP3 BRD2 FANCI SNRPD1 PRDM15 YIPF6	1.78e-05	1215	105	14	15146197
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	ABCC1 MYO5A CENPF CNTRL STXBP3 BRD2 ANO6 FANCI ATP2B1 ATP2B4 YIPF6	1.82e-05	754	105	11	33060197
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	ZBTB33 POTEF CHD8 TASOR2 POTEE POTEI SNRPD1	1.92e-05	271	105	7	32433965
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DMXL2 TBC1D30 ARMCX2 SMYD4 RFTN1 POP1 CDC5L PDZRN3 PDZRN4	1.94e-05	493	105	9	15368895
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	CUL3 KRT9 MYO5A CENPF HNRNPF SDAD1 NSD3 TASOR2 ITPR2 UTP18 POP1 KIF5B CDC5L SNRPD1	2.58e-05	1257	105	14	36526897
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	CUL3 CEP162 FBRS NSD3 BRD2 FAM50A RBPJ SGO2 KIF5B PRDM15	2.67e-05	645	105	10	25281560
Pubmed	Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.	MYH7 TNNT2	2.70e-05	3	105	2	33588347
Pubmed	Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells.	ABCC1 RBPJ	2.70e-05	3	105	2	22143792
Pubmed	Expression of the fast twitch troponin complex, fTnT, fTnI and fTnC, in vascular smooth muscle.	TNNI2 TNNT2	2.70e-05	3	105	2	18548613
Pubmed	Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy.	MYH7 TNNT2	2.70e-05	3	105	2	12473556
Pubmed	UBAP2L-dependent coupling of PLK1 localization and stability during mitosis.	CUL3 PLK1	2.70e-05	3	105	2	37039032
Pubmed	RhoBTB3 interacts with the 5-HT7a receptor and inhibits its proteasomal degradation.	CUL3 RHOBTB3	2.70e-05	3	105	2	22245496
Pubmed	A complex of Neuroplastin and Plasma Membrane Ca2+ ATPase controls T cell activation.	ATP2B1 ATP2B4	2.70e-05	3	105	2	28827723
Pubmed	Dextrocardia and symmetric hypertrophic cardiomyopathy with multiple mutations of genes encoding the sarcomere proteins.	MYH7 TNNT2	2.70e-05	3	105	2	25863306
Pubmed	Prevalence and Phenotypic Expression of Mutations in the MYH7, MYBPC3 and TNNT2 Genes in Families with Hypertrophic Cardiomyopathy in the South of Brazil: A Cross-Sectional Study.	MYH7 TNNT2	2.70e-05	3	105	2	27737317
Pubmed	Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.	MYH7 TNNT2	2.70e-05	3	105	2	24093860
Pubmed	Plasma membrane Ca2+ ATPase 1 (PMCA1) but not PMCA4 is critical for B-cell development and Ca2+ homeostasis in mice.	ATP2B1 ATP2B4	2.70e-05	3	105	2	33098669
Pubmed	Mutation spectrum in a large cohort of unrelated Chinese patients with hypertrophic cardiomyopathy.	MYH7 TNNT2	2.70e-05	3	105	2	23711808
Pubmed	Identification and characterization of PDZRN3 and PDZRN4 genes in silico.	PDZRN3 PDZRN4	2.70e-05	3	105	2	15010864
Pubmed	Evolution and expression of chimeric POTE-actin genes in the human genome.	POTEF POTEE	2.70e-05	3	105	2	17101985
Pubmed	Mutations in sarcomere protein genes in left ventricular noncompaction.	MYH7 TNNT2	2.70e-05	3	105	2	18506004
Pubmed	Mutations profile in Chinese patients with hypertrophic cardiomyopathy.	MYH7 TNNT2	2.70e-05	3	105	2	15563892
Pubmed	[Study of mutations causing hypertrophic cardiomyopathy in a group of patients from Espirito Santo, Brazil].	MYH7 TNNT2	2.70e-05	3	105	2	20414521
Pubmed	A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort.	MYH7 TNNT2	2.70e-05	3	105	2	27483260
Pubmed	CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity.	ATP2B1 ATP2B4	2.70e-05	3	105	2	15133509
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ZBTB33 FAM76B CHD8 HNRNPF NSD3 TASOR2 BRD2 FANCI BRD9 SGO2 CDC5L TAF6	3.19e-05	954	105	12	36373674
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	ZBTB33 RHOBTB3 FBRS CHD8 PRDM5 NSD3 BRD2 CADPS BRPF1 BRD9 TAF6 ZDHHC13 PDZRN3	3.25e-05	1116	105	13	31753913
Pubmed	Myocardial Mycn is essential for mouse ventricular wall morphogenesis.	MYH7 TNNI2 TNNT2	3.42e-05	21	105	3	23063798
Pubmed	Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European Americans and Blacks: a meta-analysis from atherosclerosis risk in communities and cardiovascular health studies.	STARD7 TRAM1 TNNT2	3.95e-05	22	105	3	23247143
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	CCDC125 DENND5B CHD8 ZNF236 HNRNPF PREX2 BRD2 FAM50A VPS35 DEPDC5 TAF6 PLK1 SNRPD1 GABPB1	4.65e-05	1327	105	14	32694731
Pubmed	Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons.	ATP2B1 ATP2B4	5.40e-05	4	105	2	12209837
Pubmed	Expression and role of calcium-ATPase pump and sodium-calcium exchanger in differentiated trophoblasts from human term placenta.	ATP2B1 ATP2B4	5.40e-05	4	105	2	12784250
Pubmed	Identification of pathogenic variants in genes related to channelopathy and cardiomyopathy in Korean sudden cardiac arrest survivors.	MYH7 TNNT2	5.40e-05	4	105	2	28202948
Pubmed	Impact of QT variables on clinical outcome of genotyped hypertrophic cardiomyopathy.	MYH7 TNNT2	5.40e-05	4	105	2	19149795
Pubmed	Calcium pumps of plasma membrane and cell interior.	ATP2B1 ATP2B4	5.40e-05	4	105	2	15101689
Pubmed	CUL3 and protein kinases: insights from PLK1/KLHL22 interaction.	CUL3 PLK1	5.40e-05	4	105	2	24067371
Pubmed	The plasma membrane calcium pump in health and disease.	ATP2B1 ATP2B4	5.40e-05	4	105	2	23413890
Pubmed	Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.	ATP2B1 ATP2B4	5.40e-05	4	105	2	8245032
Pubmed	Plasma membrane calcium ATPases as critical regulators of calcium homeostasis during neuronal cell function.	ATP2B1 ATP2B4	5.40e-05	4	105	2	10577388
Pubmed	Myosin5a tail associates directly with Rab3A-containing compartments in neurons.	MYO5A KIF5B	5.40e-05	4	105	2	21349835
Pubmed	Structural organization, ion transport, and energy transduction of P-type ATPases.	ATP2B1 ATP2B4	5.40e-05	4	105	2	8634322
Pubmed	Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy.	MYH7 TNNT2	5.40e-05	4	105	2	20624503
Pubmed	Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes.	ATP2B1 ATP2B4	5.40e-05	4	105	2	7989379
Pubmed	Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps.	ATP2B1 ATP2B4	5.40e-05	4	105	2	11152753
Pubmed	Development of a high resolution melting method for the detection of genetic variations in hypertrophic cardiomyopathy.	MYH7 TNNT2	5.40e-05	4	105	2	20800588
Pubmed	The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex.	ATP2B1 ATP2B4	5.40e-05	4	105	2	16735509
Pubmed	PMCA1 depletion in mouse eggs amplifies calcium signaling and impacts offspring growth†.	ATP2B1 ATP2B4	5.40e-05	4	105	2	36130203
Pubmed	Ca2+ Homeostasis by Plasma Membrane Ca2+ ATPase (PMCA) 1 Is Essential for the Development of DP Thymocytes.	ATP2B1 ATP2B4	5.40e-05	4	105	2	36674959
Pubmed	Developmental expression of the four plasma membrane calcium ATPase (Pmca) genes in the mouse.	ATP2B1 ATP2B4	5.40e-05	4	105	2	10434059
Pubmed	Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group.	MYH7 TNNT2	5.40e-05	4	105	2	25892673
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	CUL3 KRT9 CEP162 CNTRL TEX9 HOOK3 STXBP3 BRPF1 KIF5B PLK1 PDZRN3	5.56e-05	853	105	11	28718761
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	FBRS MCM2 CHD8 HNRNPF SDAD1 ITPR2 POP1 SGO2	5.89e-05	440	105	8	34244565
Pubmed	ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold.	CUL3 KRT9 MCM2 ZNF236 ZNF557 UTP18 VPS35 KIF5B	6.99e-05	451	105	8	36168627
Pubmed	Characterization of RhoBTB-dependent Cul3 ubiquitin ligase complexes--evidence for an autoregulatory mechanism.	CUL3 RHOBTB3	8.97e-05	5	105	2	18835386
Pubmed	Cullin-3-RING ubiquitin ligase activity is required for striated muscle function in mice.	CUL3 TNNT2	8.97e-05	5	105	2	29653945
Pubmed	Crystal structure of troponin C in complex with troponin I fragment at 2.3-A resolution.	TNNI2 TNNT2	8.97e-05	5	105	2	9560191
Pubmed	Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy.	MYH7 TNNT2	8.97e-05	5	105	2	12974739
Pubmed	NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler.	CHD8 NSD3	8.97e-05	5	105	2	26626481
Pubmed	Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.	MYH7 TNNT2	8.97e-05	5	105	2	23782526
Pubmed	Increased maternofetal calcium flux in parathyroid hormone-related protein-null mice.	ATP2B1 ATP2B4	8.97e-05	5	105	2	18258656
Pubmed	Differential regulation of the apical plasma membrane Ca(2+) -ATPase by protein kinase A in parotid acinar cells.	ATP2B1 ATP2B4	8.97e-05	5	105	2	17938178
Pubmed	[Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy].	MYH7 TNNT2	8.97e-05	5	105	2	19150014
Pubmed	ATR-mediated phosphorylation of FANCI regulates dormant origin firing in response to replication stress.	MCM2 FANCI	8.97e-05	5	105	2	25843623
Interaction	POTEG interactions	POTEF POTEG POTEC POTEH	3.21e-07	12	104	4	int:POTEG
Interaction	POTEC interactions	POTEB3 POTEF POTEG POTEC	4.62e-07	13	104	4	int:POTEC
Interaction	ZNF557 interactions	CCDC125 CUL3 NSD3 ZNF557	1.94e-06	18	104	4	int:ZNF557
Interaction	POTEH interactions	POTEG POTEH	2.64e-05	2	104	2	int:POTEH
Interaction	POTEB3 interactions	POTEB3 POTEF POTEC PDZRN3	3.10e-05	35	104	4	int:POTEB3
Interaction	NSD3 interactions	CUL3 CHD8 NSD3 ZNF557 BRD2 BRD9	3.21e-05	117	104	6	int:NSD3
Interaction	H3C3 interactions	MCM2 CHD8 NSD3 BRD2 FAM50A FANCI BRPF1 RBPJ BRD9 SGO2 PRDM15	5.01e-05	495	104	11	int:H3C3
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTEF POTEG POTEC POTEE POTEM POTEI POTEH	9.39e-15	13	65	7	685
GeneFamily	Ankyrin repeat domain containing	POTEF POTEG POTEC POTEE POTEM POTEI ZDHHC13 POTEH GABPB1	1.98e-07	242	65	9	403
GeneFamily	EF-hand domain containing\|Troponin complex subunits	TNNI2 TNNT2	3.51e-04	8	65	2	1219
GeneFamily	ATPases Ca2+ transporting	ATP2B1 ATP2B4	4.51e-04	9	65	2	1209
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	PRDM5 PRDM15	1.67e-03	17	65	2	1197
GeneFamily	PWWP domain containing	NSD3 BRPF1	2.81e-03	22	65	2	1147
Coexpression	RAO_BOUND_BY_SALL4_ISOFORM_B	POTEB3 IRGM POTEF POTEG POTEC NSD3 POTEE ZFAND1 POTEM BRPF1 RBPJ POTEI POTEH GABPB1	8.04e-08	584	104	14	MM1080
Coexpression	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	ABCC1 CENPF MCM2 FHOD3 FANCI LRRC1 SGO2	7.49e-06	179	104	7	M3268
Coexpression	BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP	CENPF SGO2 CCDC144A	1.30e-05	12	104	3	M34000
Coexpression	GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP	ZBTB33 LRRC1 BRD9 SGO2 CDC5L PLK1 PURG	1.54e-05	200	104	7	M5066
Coexpression	GSE369_SOCS3_KO_VS_WT_LIVER_DN	CCDC125 FAM76B FHOD3 NSD3 FICD HOOK3 BRD9	1.54e-05	200	104	7	M5963
Coexpression	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	CUL3 CENPF MCM2 HNRNPF NSD3 SMYD4 MRO CNIH4 FANCI POP1 SGO2 KIF5B CDC5L PLK1 SNRPD1 GABPB1	4.80e-05	1290	104	16	M80
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH7 CLXN LAMP5 HERC6 TNNT2 ATP2B4 PDZRN3	9.01e-08	156	105	7	09e0702400570089d9012dcf94dfb4827c97e49d
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DENND5B TEX9 POTEE FICD POTEM PLK1 CCDC144A	2.30e-07	179	105	7	021d782134126c6f7dce6b6ea50cc54bdaa39987
ToppCell	metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ\|metastatic_Lymph_Node / Location, Cell class and cell subclass	CENPF RFTN1 FANCI SGO2 PLK1 SNRPD1 CCDC144A	4.10e-07	195	105	7	3c5b7cce4a1c4b28fa3b657cce4148669a59e55e
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Rrad\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH7 CLXN CENPF LAMP5 ATP2B4 PDZRN3	9.36e-07	138	105	6	b3a040c5d0e1cc94d9b19155bca8700edba2d243
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH7 CLXN LAMP5 ATP2B4 PDZRN3 PDZRN4	1.91e-06	156	105	6	2cd007b423c2395c5ce331902e7f27c805755eb3
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	LAMP5 CFAP43 ZNF557 POSTN CADPS PLK1	1.99e-06	157	105	6	f6210be2362d833c6d869ff921188bfc85dda11d
ToppCell	356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	LAMP5 CFAP43 ZNF557 POSTN CADPS PLK1	1.99e-06	157	105	6	43a6b423fd70479822a564ff4225a1e4951ae5ed
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-9\|TCGA-Breast / Sample_Type by Project: Shred V9	POTEF POTEE POTEM POTEI POTEH	2.36e-06	90	105	5	96e836c7a1df279ac812b7c3aa75e6b81b614244
ToppCell	COVID-19-Heart-CM_+_Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	DMXL2 MYH7 MYO5A FHOD3 RBPJ TNNT2	3.15e-06	170	105	6	4232fe937909f93d3736988c707b8f95ce993398
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPF MCM2 ANO6 FANCI SGO2 PLK1	3.37e-06	172	105	6	2b6cd84c946b1e800caba452ae70145ea285fec1
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DENND5B CENPF MCM2 TEX9 FANCI PLK1	3.72e-06	175	105	6	89bf89466191da14896ed8928027f5b911436c22
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	POTEF POTEG LAMP5 POTEE ANO6 POTEI	4.37e-06	180	105	6	fb3d549c2a69b2157a486786ddd775ca16699ed0
ToppCell	Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	POTEF POTEG LAMP5 POTEE ANO6 POTEI	4.37e-06	180	105	6	beb4d777e0c5fa0a59672dbc3dbb7732498605ff
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CENPF MCM2 SDAD1 SGO2 PLK1 ZDHHC13	4.81e-06	183	105	6	6c1d7ce60e67bf1df364a4e177c351e7313eb41f
ToppCell	normal-na-Lymphocytic-lymphocyte-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	ZNF337 RHOBTB3 FAM76B MCM2 ZNF557 DEPDC5	4.96e-06	184	105	6	2c286712428662bc4589dc5ac4011bf7ed403cb5
ToppCell	3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|lymph-node_spleen / Manually curated celltypes from each tissue	CENPF NAB1 SGO2 PLK1 ZDHHC13 PRDM15	5.44e-06	187	105	6	3c10b8501226c69d71bcd99dc1c064a3c2154f87
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	MYH7 STARD7 FHOD3 TNNT2 ATP2B4 PDZRN3	5.78e-06	189	105	6	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	normal_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ\|normal_Lymph_Node / Location, Cell class and cell subclass	CENPF MCM2 FHOD3 FANCI PLK1 CCDC144A	6.52e-06	193	105	6	5ce93860bc60ce6ecfed3a3d985f84e28781eec1
ToppCell	wk_15-18-Hematologic_Lymphocytic-T_&_ILC-Cycling_T\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CENPF GIMAP7 FANCI OXNAD1 SGO2 PLK1	6.52e-06	193	105	6	bec113472c40c0106a9427248cbcf54548797596
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLXN EFCAB6 CFAP43 TEX9 CCDC191 HYDIN	6.72e-06	194	105	6	4a2c127c90d1fefe604fcb9e796577d21b489dd6
ToppCell	control-Lymphocytic-Prol._cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	6.72e-06	194	105	6	4c76508de3291c952386caffda2d559629ba5998
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CNTRL GIMAP7 RFTN1 BRD9 OXNAD1 ATP2B4	6.92e-06	195	105	6	4b9663509cc5e3f409f6d0d37640cb301a827d98
ToppCell	Healthy/Control-T/NK_proliferative\|Healthy/Control / Disease group and Cell class	CENPF MCM2 FANCI SGO2 PLK1 HYDIN	6.92e-06	195	105	6	957458fdc39723f4a31bd7fd3ce32891aa3fd462
ToppCell	ILEUM-non-inflamed-(1)_Highly_activated_T_cells\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.12e-06	196	105	6	6a415a2574bd84bd825a2bd6c8e3632a433ff7cf
ToppCell	severe-T/NK_proliferative\|severe / disease stage, cell group and cell class	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.12e-06	196	105	6	89f005216770dbb84378f5d1f20ca11b0ce40faa
ToppCell	severe-T/NK_proliferative\|World / disease stage, cell group and cell class	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.33e-06	197	105	6	6b7b068b103fd4f6ceda8e01f4dd39eefc3b3633
ToppCell	(4)_B_cells-(4)_B_Hypermutation\|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	CENPF MCM2 LAMP5 FANCI SGO2 PLK1	7.55e-06	198	105	6	8be724a49b4c911d68c3e82fb75e96722d0eaa03
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CENPF CNTRL CNIH4 SGO2 KIF5B PLK1	7.55e-06	198	105	6	c3dd887c95587f930b7afd32385627a9fa029ca4
ToppCell	(11)_FOXN4+\|World / shred by cell type by condition	CLXN CENPF CEP162 CNTRL FANCI SGO2	7.55e-06	198	105	6	516b1acdf997dd8debc3dca066519366e507b414
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.77e-06	199	105	6	4394dcd1809f49e9bada8f5e115d5123356eae3e
ToppCell	Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative\|Leuk-UTI / Disease, Lineage and Cell Type	CENPF MCM2 PRDM5 FANCI SGO2 PLK1	7.77e-06	199	105	6	87113d398585076ece86b9098781e817f8ca241b
ToppCell	remission-T/NK_proliferative\|remission / disease stage, cell group and cell class	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.77e-06	199	105	6	303a5fc43a48b05b6f2060d99eef4adc36f8d4e3
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.77e-06	199	105	6	c0ea391bb347b99b94b5d7f02612ede938986745
ToppCell	NS-critical-d_16-33-Lymphoid-NKT-proliferating\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CENPF MCM2 RFTN1 FANCI SGO2 PLK1	7.77e-06	199	105	6	31b144bb209c629e12156f4d9c9cec79baffffb9
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.77e-06	199	105	6	96af1f289552f38f2dfa181192eb3276f4c7d70b
ToppCell	remission-T/NK_proliferative\|World / disease stage, cell group and cell class	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.77e-06	199	105	6	f305f3a454b7d2170429bad087480ccccca19acd
ToppCell	COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Convalescent / Disease group, lineage and cell class	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.77e-06	199	105	6	893b78c661c529db07a5fcc3124d9b3d0f270fa5
ToppCell	COVID-19_Convalescent-T/NK_proliferative\|COVID-19_Convalescent / Disease condition and Cell class	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.77e-06	199	105	6	c608d953b852b67a4e36bd63d45f0deec3eefbd9
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.77e-06	199	105	6	5b18e18ddbf4bd53aa0d574d23092cb96da7f400
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.77e-06	199	105	6	6df65f4c2f9a125e0c7c4f597fefc05a97fc8831
ToppCell	severe-Lymphocytic-Prol._cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.77e-06	199	105	6	b24315952b6ac6c8d2d3a7bd949a5b5392624d4e
ToppCell	PBMC-Convalescent-Lymphocyte-T/NK-Other_T\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.77e-06	199	105	6	cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell\|2m / Sample Type, Dataset, Time_group, and Cell type.	CENPF CNTRL MCM2 FANCI SGO2 PLK1	7.99e-06	200	105	6	0d9b8d51a7630e70e60c76c763ff82df4c559152
ToppCell	NS-moderate-d_07-13-Lymphoid-NKT-proliferating\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CENPF MCM2 GIMAP7 FANCI SGO2 PLK1	7.99e-06	200	105	6	87e293c0882e2754756a2210a6c04723dc89f81b
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells\|2m / Sample Type, Dataset, Time_group, and Cell type.	CENPF CNTRL MCM2 FANCI SGO2 PLK1	7.99e-06	200	105	6	0675f580ccef705875854247bbfd4ee2bcf126a1
ToppCell	Severe-T/NK_proliferative\|Severe / Disease group and Cell class	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.99e-06	200	105	6	4723613a9f56bff422fc98722128d57b6adf3c5d
ToppCell	COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CENPF MCM2 HNRNPF FANCI SGO2 PLK1	7.99e-06	200	105	6	04bf9e6a0fbd792b49eed63dabba5d6fafed8c07
ToppCell	Severe-T/NK_proliferative\|World / Disease group and Cell class	CENPF MCM2 FANCI SGO2 PLK1 SNRPD1	7.99e-06	200	105	6	128d82eb4d5760adf872212d8e8b5787a889969f
ToppCell	COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CENPF MCM2 HNRNPF FANCI SGO2 PLK1	7.99e-06	200	105	6	f6b5320cdfe640a71e6e2df26f30d42e64b1c921
ToppCell	TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11\|TCGA-Brain / Sample_Type by Project: Shred V9	POTEF POTEG POTEE POTEI	1.50e-05	63	105	4	d7dc1356a60cb527fe668328d5375f352239d911
ToppCell	390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	CENPF MCM2 FANCI SGO2 PLK1	3.76e-05	159	105	5	0fbfdb18b7ed4bde077add13f2b3636e144b254f
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Cbln4_Fezf2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LAMP5 FHOD3 POSTN HERC6 PDZRN3	3.87e-05	160	105	5	d8241404d775f9a709abdf17988f36293fcf4c58
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MYH7 CLXN LAMP5 ATP2B4 PDZRN3	3.99e-05	161	105	5	e3327c296d48e821004e61a573abb75624a6f040
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	CENPF PKD1L3 ITPR2 HERC6 APOL2	4.23e-05	163	105	5	d005115aa1e1458b51de7eb719794617a4168608
ToppCell	Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.Fibcd1-Lypd1_(CA1_Principal_cells_(Anterior))\|Hippocampus / BrainAtlas - Mouse McCarroll V32	MYH7 EFCAB6 BRD9 ATP2B1	4.68e-05	84	105	4	52d167614afa9b056f2934142d3250fe5e70e806
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EFCAB6 CFAP43 TEX9 CCDC191 HYDIN	5.02e-05	169	105	5	fba841664939c771881ba97f14ef1df6635c04ff
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DENND5B CENPF MCM2 PLK1 POTEH	5.31e-05	171	105	5	13126a3fbee181412c13ffb0c347277b9d8f16f7
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	CENPF SGO2 PLK1 SNRPD1 PRDM15	5.46e-05	172	105	5	7f3d0ef18f5df1ed80498d435b0378ca398c0b88
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC1 CENPF PKD1L3 FANCI SGO2	5.46e-05	172	105	5	94093d356b0252b440deda4e1b0ac332b31513f6
ToppCell	10x5'-bone_marrow-Lymphocytic_NK-Cycling_NK\|bone_marrow / Manually curated celltypes from each tissue	CENPF MCM2 FANCI SGO2 PLK1	5.61e-05	173	105	5	8a9dd85f718564c07cf3120ad648daeb60c94fc5
ToppCell	Healthy_donor-Plasmablast\|World / disease group, cell group and cell class (v2)	DENND5B MCM2 TEX9 SGO2 PLK1	5.93e-05	175	105	5	5293e00fda63a291aa393bdf82ebd4b80265049f
ToppCell	Dividing_Macrophages-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	CENPF CCDC168 FANCI SGO2 PLK1	5.93e-05	175	105	5	0a8bf455babb3271aa00642199fb58b0b02dc3ac
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CENPF MCM2 FANCI SGO2 PLK1	5.93e-05	175	105	5	6b4e841bde6cfa4956e1a0231672cea20f11210c
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CYP8B1 FANCI SGO2 TNNI2 PLK1	6.09e-05	176	105	5	581045e61cdcdfa85701343d1a7c0a72a36606a7
ToppCell	367C-Myeloid-Dendritic-cDC_proliferating_1\|367C / Donor, Lineage, Cell class and subclass (all cells)	CENPF MCM2 FANCI SGO2 PLK1	6.26e-05	177	105	5	ba701d3c90722d8bff70d0fa651899305cdad257
ToppCell	Ciliated_cells-A-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	CLXN EFCAB6 CFAP43 CNIH4 HYDIN	6.43e-05	178	105	5	255473ee6df8a13079fb3bb61038162a40cb4c2c
ToppCell	Healthy_donor-Plasmablast\|Healthy_donor / disease group, cell group and cell class (v2)	DENND5B CENPF MCM2 TEX9 PLK1	6.43e-05	178	105	5	388b8b4fa20dcc6e9ae4b06118e20b2c20c52bde
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	CENPF CNIH4 SGO2 PLK1 SNRPD1	6.77e-05	180	105	5	ed4966765a6b25456f68185cf0648c4a3a21d7fe
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CLXN TNNT2 ATP2B4 CCDC144A PDZRN4	7.14e-05	182	105	5	31efc06d6b073e8e341648207093e5f33c6f9183
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T\|bone_marrow / Manually curated celltypes from each tissue	CENPF MCM2 FANCI SGO2 PLK1	7.32e-05	183	105	5	a48a6313f2f144586951cece97ec31f6d72361df
ToppCell	mild_COVID-19_(asymptomatic)-T/NK_proliferative\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	CENPF MCM2 FANCI SGO2 PLK1	7.32e-05	183	105	5	df8568751205313d149939ea2683097e3652a60b
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CENPF MCM2 GIMAP7 SGO2 PLK1	7.51e-05	184	105	5	1edefa2a049d7e22d0bdb1ea3d7ef1c8d6ae0fe3
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-Proliferating_T_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CENPF MCM2 GIMAP7 SGO2 PLK1	7.51e-05	184	105	5	8578c50eaa8ce1cefc0228185c66c8e25f4bfc32
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMP5 RFTN1 ATP2B4 HYDIN CCDC144A	7.51e-05	184	105	5	30fddbc9696476d4d7f08e53f84ea994a4ed873a
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	LAMP5 RFTN1 ATP2B4 HYDIN CCDC144A	7.51e-05	184	105	5	96926efa220f03d0787322c9519bb9e8f64f74d0
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH7 FHOD3 CADPS TNNT2 PDZRN3	7.51e-05	184	105	5	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CENPF MCM2 FANCI TAF6 PLK1	7.71e-05	185	105	5	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH7 FHOD3 CADPS TNNT2 PDZRN3	7.71e-05	185	105	5	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CENPF CNTRL FANCI SGO2 PLK1	8.11e-05	187	105	5	73931a5ea73799095daff100b5f18853c57c74dc
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative\|Multiple_Sclerosis / Disease, Lineage and Cell Type	CENPF MCM2 FANCI SGO2 PLK1	8.32e-05	188	105	5	6c05797a5d0635d89ffcf4aca52178687129ccb4
ToppCell	Adult-Epithelial-ciliated_cell-D231\|Adult / Lineage, Cell type, age group and donor	CLXN EFCAB6 FHOD3 CFAP43 HYDIN	8.32e-05	188	105	5	34b11f72ca73153d02edcd09b38983ad1a504659
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLXN CFAP43 ITPR2 CCDC191 HYDIN	8.53e-05	189	105	5	cd4746ea6ae48a7dd14a2960d38d9445a738cf2c
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	CLXN EFCAB6 CFAP43 TEX9 HYDIN	8.53e-05	189	105	5	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	Int-URO-Lymphocyte-T_NK-T_NK_proliferative\|Int-URO / Disease, Lineage and Cell Type	CENPF MCM2 FANCI SGO2 PLK1	8.74e-05	190	105	5	005967c540418b85311308072a07c684f4296aef
ToppCell	(02)_Cycling_Basal_(regeneration)\|World / shred by cell type and Timepoint	CENPF MCM2 SGO2 PLK1 SNRPD1	8.74e-05	190	105	5	53f017a11ca5ebe9025558e12cedc409cab2e5aa
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CENPF ARMCX2 POSTN SGO2 PLK1	8.96e-05	191	105	5	ddbc5f97f2aef19be4ad93db4139876c939b848e
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CENPF MCM2 FANCI SGO2 PLK1	8.96e-05	191	105	5	15dbc5a03bfab8931c0fd385b0f25874736ae874
ToppCell	Mild-T/NK_proliferative\|World / Disease group and Cell class	CENPF MCM2 FANCI SGO2 PLK1	8.96e-05	191	105	5	9dba5526fd5ea8065ad305feb2ee562335f887c6
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CENPF MCM2 FANCI SGO2 PLK1	8.96e-05	191	105	5	45c15f5ce4a207ac944bed65d45f06c1657d1a6d
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CENPF MCF2 MCM2 FANCI SGO2	8.96e-05	191	105	5	50854384fdaa0efa2e3227659d544ed09ac102f2
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLXN CFAP43 TEX9 CCDC191 HYDIN	9.18e-05	192	105	5	1b6cac8156e608061e1405e36e18d185b6fa8f6f
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	CLXN EFCAB6 CFAP43 TEX9 HYDIN	9.41e-05	193	105	5	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	P07-Endothelial-proliferative_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CENPF MCM2 HNRNPF SGO2 PLK1	9.41e-05	193	105	5	1e95ef29357969ee385b4717c0b5a497390ac260
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	MYH7 FHOD3 TNNT2 ATP2B4 PDZRN3	9.41e-05	193	105	5	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CENPF MCM2 FANCI SGO2 PLK1	9.41e-05	193	105	5	cf680afddc08b6481f1b3eee9c57acfaebeac6f0
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_DC1\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CENPF LRRC1 SGO2 TNNI2 PLK1	9.41e-05	193	105	5	42775588e788c330aade07e54b208f1c2eea3ab3
ToppCell	control-T/NK_proliferative\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	CENPF MCM2 FANCI SGO2 PLK1	9.41e-05	193	105	5	ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d
ToppCell	P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CENPF MCM2 HNRNPF SGO2 PLK1	9.41e-05	193	105	5	0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd
ToppCell	(3)_Chondrocytes-(33)_Chondro-prol/rest\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	CLXN CENPF SGO2 TNNI2 PLK1	9.64e-05	194	105	5	c093c5e161b97ad770bfbaad3023eba4537101b5
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	CENPF MCM2 FANCI SGO2 PLK1	9.64e-05	194	105	5	17af04acd54dd6a895a966cbb4422de25dc4f1e6
Computational	Neighborhood of CKS2	CENPF MCM2 FANCI SNRPD1	1.46e-04	50	58	4	GNF2_CKS2
Computational	Neighborhood of FEN1	CENPF MCM2 FANCI SNRPD1	2.27e-04	56	58	4	GNF2_FEN1
Computational	Neighborhood of RFC4	CENPF MCM2 FANCI SNRPD1	2.97e-04	60	58	4	GNF2_RFC4
Computational	Neighborhood of CCNA2	CENPF MCM2 FANCI PLK1	4.81e-04	68	58	4	GNF2_CCNA2
Disease	Hailey-Hailey disease (implicated_via_orthology)	ATP2B1 ATP2B4	1.53e-04	6	95	2	DOID:0050429 (implicated_via_orthology)
Disease	Idiopathic hypertrophic subaortic stenosis	MYH7 TNNT2	2.13e-04	7	95	2	C0700053
Disease	Obstructive asymmetric septal hypertrophy	MYH7 TNNT2	2.13e-04	7	95	2	C0597124
Disease	dilated cardiomyopathy (is_implicated_in)	MYH7 RBPJ TNNT2	3.63e-04	43	95	3	DOID:12930 (is_implicated_in)
Disease	familial hypertrophic cardiomyopathy (is_implicated_in)	FHOD3 TNNT2	3.64e-04	9	95	2	DOID:0080326 (is_implicated_in)
Disease	Cardiomyopathy, Hypertrophic, Familial	MYH7 TNNT2	3.64e-04	9	95	2	C0949658
Disease	Ischemic stroke	ABCC1 NYNRIN POP1 CDC5L ATP2B1 PDZRN4	6.41e-04	324	95	6	HP_0002140
Disease	Hypertrophic Cardiomyopathy	MYH7 FHOD3 TNNT2	8.34e-04	57	95	3	C0007194
Disease	Left ventricular noncompaction	MYH7 TNNT2	9.10e-04	14	95	2	C1960469
Disease	distal arthrogryposis (implicated_via_orthology)	MYH7 TNNI2	1.05e-03	15	95	2	DOID:0050646 (implicated_via_orthology)
Disease	Liver carcinoma	CENPF MCM2 MRO FANCI LRRC1 DEPDC5 PLK1	1.28e-03	507	95	7	C2239176
Disease	cardiomyopathy (implicated_via_orthology)	MYH7 TNNI2 TNNT2	1.58e-03	71	95	3	DOID:0050700 (implicated_via_orthology)
Disease	pulse pressure measurement	CNTRL NAB1 FAM76B FHOD3 PKD1L3 NSD3 MRO TET1 LRRC1 KIF5B ATP2B1 HYDIN	1.70e-03	1392	95	12	EFO_0005763
Disease	haptoglobin measurement	PKD1L3 HYDIN	2.07e-03	21	95	2	EFO_0004640
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH7 CENPF TNNI2	2.22e-03	80	95	3	DOID:12930 (implicated_via_orthology)
Disease	hypertrophic cardiomyopathy (is_implicated_in)	MYH7 TNNT2	2.27e-03	22	95	2	DOID:11984 (is_implicated_in)
Disease	Primary familial hypertrophic cardiomyopathy	MYH7 TNNT2	2.27e-03	22	95	2	cv:C0949658
Disease	lateral orbital frontal cortex volume measurement	RFTN1 OXNAD1	2.70e-03	24	95	2	EFO_0010312
Disease	Hypertrophic obstructive cardiomyopathy	MYH7 TNNT2	2.93e-03	25	95	2	C4551472
Disease	apolipoprotein L1 measurement	PKD1L3 APOL2	2.93e-03	25	95	2	EFO_0021854

Protein segments in the cluster

Peptide	Gene	Start	Entry
GKTNNHMLKLAMDLK	PRPF4B	891	Q13523
LNKLASHMVMKDKNR	APOL2	56	Q9BQE5
AKMIKDVEMHNLAKS	CFAP43	861	Q8NDM7
QKLKRFKTKMAQMRH	CHD8	696	Q9HCK8
GHMTTEAKRAAKMEK	CDC5L	701	Q99459
MSKHKTELKNILDML	CNTRL	1691	Q7Z7A1
AKKILHAGFKMMSKQ	BRD9	226	Q9H8M2
GKAKVIHKESDMIMA	DMXL2	2651	Q8TDJ6
MINKTDPHIKEKALM	ARMCX2	436	Q7L311
SVKKMMKDNNLVRHL	ATP2B1	446	P20020
SVKKMMKDNNLVRHL	ATP2B4	436	P23634
NILELSHKKMMKKRN	PDZRN3	1016	Q9UPQ7
NIIELSHKKMMKKRN	PDZRN4	986	Q6ZMN7
REEMHNRQMRKSKGK	RFTN1	451	Q14699
AFMSKLINHTKKLME	ITPR2	1651	Q14571
IMHFGNMKFKLKQRE	MYH7	356	P12883
MKKFISANQLKRHMI	PRDM5	326	Q9NQX1
MLCKEAKLEMVHKSR	PALM2	236	Q8IXS6
HQKKRAAEMMASLLK	KIF5B	546	P33176
FRMNKFSHDLKRKMI	MCM2	886	P49736
KLLHENHLKDMTKNM	ANO6	876	Q4KMQ2
KLAVRMDKPQNMKHS	CADPS	511	Q9ULU8
MGRTFHKVTLKDKMI	DEPDC5	856	O75140
MQHMKLSTSRDFKIK	FANCI	1276	Q9NVI1
HDDSAMKTLRNKMGK	POTEF	86	A5A3E0
TSGSEMANKRMKVKH	ZBTB33	466	Q86T24
MALKKNHKEEMSQLT	KRT9	286	P35527
KKLAKMIGHIFEMND	NAB1	226	Q13506
NHVMLAKTAEDMGKK	IRGM	126	A1A4Y4
KREKAQKLFMHALKM	FICD	121	Q9BVA6
LKHGADVNAKDMLKM	GABPB1	91	Q06547
RNDSMKAALRKMLSK	OR14J1	291	Q9UGF5
ALLGMMKELHKVNKA	HERC6	561	Q8IVU3
LRTKMNSMEKAHKET	FAM76B	291	Q5HYJ3
ALKMLFVKESHNMSK	LAMP5	116	Q9UJQ1
SAKKRHMAMRNLGTM	MRO	61	Q9BYG7
NMGMTLHKKAAEDRL	HOOK3	671	Q86VS8
LKHMKKTVENLRNDM	LRRC1	486	Q9BTT6
LRNKDMKQGLAKLMH	OR1L1	341	Q8NH94
MLQSEIQAMKKLRHK	PTK6	231	Q13882
HDNSFMKTLRSKMGK	POTEB3	86	A0JP26
IMKSKRKTDHMERTA	OXNAD1	41	Q96HP4
HDDSAMKTLRNKMGK	POTEE	86	Q6S8J3
MSNAKERKHAKKMRN	POP1	1	Q99575
GIIMKLKEQHSKIDM	FGFR1OP2	121	Q9NVK5
MILRHQEKMKGDSHK	FBRS	96	Q9HAH7
ELNKKKRNMGDVSMH	HYDIN	2416	Q4G0P3
ALQLTQMDKMHKKAT	CCDC125	341	Q86Z20
MEEMKKENNLLKSHS	CENPF	481	P49454
LLKAKESSLMHRMKI	EFCAB6	1391	Q5THR3
AGRAMHLMKKREKQR	FAM50A	11	Q14320
MKSRKKMQHNVLVAE	CUL3	711	Q13618
KDPRLTMEMRHKQVK	CCDC191	186	Q8NCU4
AIAKHEMKPVLKQRM	FHOD3	1181	Q2V2M9
KTKRMLVEKMGHEAV	DENND5B	746	Q6ZUT9
HFVGLEKKIKQMEMR	CEP162	1311	Q5TB80
TKMKDLARFKPMQRH	MCF2	711	P10911
NRQKMDFSKKLRMKH	CCDC168	3166	Q8NDH2
HDKMKVDMSGLQAKN	CCDC144A	951	A2RUR9
KNMFEFLKRMRTKHG	CYP8B1	51	Q9UNU6
HILMNSSKKLMVKDR	NYNRIN	901	Q9P2P1
MRKICNSHKEKRMDG	PURG	321	Q9UJV8
KMKKRKMSNSFHGIR	RHOBTB3	206	O94955
HDNSFMKTLRSKMGK	POTEC	86	B2RU33
QVAHMKSKDNRIKLM	ABCC1	491	P33527
DVKMALKKDRESMGH	HNRNPF	66	P52597
AQDALKFMHMGKRQK	TAF6	51	P49848
KFMHMGKRQKLTTSD	TAF6	56	P49848
HLLAMKTKELIGSMK	UTP18	366	Q9Y5J1
LHRLKMKMQEKDSLT	SMYD4	191	Q8IYR2
LGKKSMKHRMDQLEA	IQCA1L	791	A6NCM1
KSFARKDMLKEHMRV	PRDM15	1091	P57071
KAVFGKSAMKHMVIL	GIMAP7	116	Q8NHV1
KSAMKHMVILFTRKE	GIMAP7	121	Q8NHV1
GLDMKSISLHKKNMA	PKD1L3	1516	Q7Z443
HEKMNKMKFKVNRRT	SGO2	1191	Q562F6
HDDSAMKTLRSKMGK	POTEI	86	P0CG38
KTHKDKNVMMSARTL	SDAD1	421	Q9NVU7
ALTQLMKKMPHFRKQ	STXBP3	326	O00186
KKRAAMMTEVLAHKI	TET1	1756	Q8NFU7
MIKKEMTALRRKLAH	BRPF1	811	P55201
KHPMDLSTVKRKMEN	BRD2	391	P25440
QLKSHMKEAMIKLGF	CNIH4	106	Q9P003
SKEEMFHMLKNSLLK	CLXN	121	Q9HAE3
EMRNKLNPYRKHMKE	NLRP9	91	Q7RTR0
AMLKALLGSKHKVCM	TNNI2	121	P48788
TIMRDLKAVGKKFMH	YIPF6	61	Q96EC8
IHMLKTEAKMRANQK	ZDHHC13	266	Q8IUH4
KNKLMDALKHASNML	VPS35	36	Q96QK1
EARKKKALSNMMHFG	TNNT2	181	P45379
MNTHLKAVKMTLKNR	SNRPD1	36	P62314
GSNMKHRLMKHDLKV	PREX2	571	Q70Z35
INHLLLGKKMKMTNR	TBC1D30	681	Q9Y2I9
KDIHKASKGRMMRCL	NSD3	806	Q9BZ95
SDSDKRKHFMLSVKM	RBPJ	131	Q06330
MLDKINRRMHFSKTK	TRAM1	101	Q15629
GFTQKSNMKLHMKRA	ZNF236	1786	Q9UL36
EKLHMATLKAKNMEI	STARD7	316	Q9NQZ5
RKASMPHMVQSKKVN	TASOR2	351	Q5VWN6
AKVALMKLKMHADGD	ZFAND1	141	Q8TCF1
HSHMINKRMLTKDLK	POSTN	166	Q15063
KLHVFRKEQSRNMKM	ZNF557	121	Q8N988
HDDSAMKTLRSKMGK	POTEG	86	Q6S5H5
HDDSAMKTLRSKMGK	POTEH	86	Q6S545
HDDSAMKTLRSKMGK	POTEM	86	A6NI47
VLKRQKMHIEAAKML	TEX9	361	Q8N6V9
GQDFSRKMMVIIHKK	ZNF337	186	Q9Y3M9
KSLLLKPHQREKMSM	PLK1	86	P53350
ERYKKLHIGMENKIM	MYO5A	916	Q9Y4I1